Erythrocytapheresis: Do Not Forget a Useful Therapy!

Standard

Erythrocytapheresis: Do Not Forget a Useful Therapy! / Ullrich, Heidrun; Fischer, Roland; Grosse, Regine; Kordes, Uwe; Schubert, Claudia; Altstadt, Bettina; Andreu, Georges.

in: TRANSFUS MED HEMOTH, Jahrgang 35, Nr. 1, 2008, S. 24-30.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Ullrich, H, Fischer, R, Grosse, R, Kordes, U, Schubert, C, Altstadt, B & Andreu, G 2008, 'Erythrocytapheresis: Do Not Forget a Useful Therapy!', TRANSFUS MED HEMOTH, Jg. 35, Nr. 1, S. 24-30. https://doi.org/10.1159/000112044

APA

Ullrich, H., Fischer, R., Grosse, R., Kordes, U., Schubert, C., Altstadt, B., & Andreu, G. (2008). Erythrocytapheresis: Do Not Forget a Useful Therapy! TRANSFUS MED HEMOTH, 35(1), 24-30. https://doi.org/10.1159/000112044

Vancouver

Ullrich H, Fischer R, Grosse R, Kordes U, Schubert C, Altstadt B et al. Erythrocytapheresis: Do Not Forget a Useful Therapy! TRANSFUS MED HEMOTH. 2008;35(1):24-30. https://doi.org/10.1159/000112044

Bibtex

@article{2abb32953a3e4aeca89d06e2e7241fde,
title = "Erythrocytapheresis: Do Not Forget a Useful Therapy!",
abstract = "SUMMARY: In patients with pathologically altered erythrocytes, red blood cell exchange is a very efficient therapeutic measure without important side effects. With increasing migration more patients with e.g. severe malaria or sickle cell anemia have to be treated. In minor or bidirectional ABO-mismatched stem cell transplantations after reduced intensity conditioning, hemolysis can be prevented by prophylactic erythrocytapheresis. Other rare indications for red blood cell exchange are advanced erythropoietic protoporphyria and babesiosis. Sickle cell anemia can be treated with hydroxyurea. Transfusions are administered when necessary, but this results in iron overload in the long term. An expensive but safe and very efficient treatment alternative is red blood cell exchange. In cases with stroke, acute chest syndrome and other severe complications, erythrocytapheresis reproducibly breaks the vicious circle of sickling and increasing oxygen deficiency. At the same time one can aim at an exact end hematocrit. In severe malaria, erythrocytapheresis both reduces parasite load to the designated extent and reconstitutes reduced oxygen transport capacity without serious adverse effects. Here we describe our experience of erythrocytapheresis in long-term prophylaxis of complications in sickle cell anemia and sickle cell thalassemia patients. The documentation of improved iron balance was carried out by liver susceptometry.",
author = "Heidrun Ullrich and Roland Fischer and Regine Grosse and Uwe Kordes and Claudia Schubert and Bettina Altstadt and Georges Andreu",
year = "2008",
doi = "10.1159/000112044",
language = "English",
volume = "35",
pages = "24--30",
journal = "TRANSFUS MED HEMOTH",
issn = "1660-3796",
publisher = "S. Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - Erythrocytapheresis: Do Not Forget a Useful Therapy!

AU - Ullrich, Heidrun

AU - Fischer, Roland

AU - Grosse, Regine

AU - Kordes, Uwe

AU - Schubert, Claudia

AU - Altstadt, Bettina

AU - Andreu, Georges

PY - 2008

Y1 - 2008

N2 - SUMMARY: In patients with pathologically altered erythrocytes, red blood cell exchange is a very efficient therapeutic measure without important side effects. With increasing migration more patients with e.g. severe malaria or sickle cell anemia have to be treated. In minor or bidirectional ABO-mismatched stem cell transplantations after reduced intensity conditioning, hemolysis can be prevented by prophylactic erythrocytapheresis. Other rare indications for red blood cell exchange are advanced erythropoietic protoporphyria and babesiosis. Sickle cell anemia can be treated with hydroxyurea. Transfusions are administered when necessary, but this results in iron overload in the long term. An expensive but safe and very efficient treatment alternative is red blood cell exchange. In cases with stroke, acute chest syndrome and other severe complications, erythrocytapheresis reproducibly breaks the vicious circle of sickling and increasing oxygen deficiency. At the same time one can aim at an exact end hematocrit. In severe malaria, erythrocytapheresis both reduces parasite load to the designated extent and reconstitutes reduced oxygen transport capacity without serious adverse effects. Here we describe our experience of erythrocytapheresis in long-term prophylaxis of complications in sickle cell anemia and sickle cell thalassemia patients. The documentation of improved iron balance was carried out by liver susceptometry.

AB - SUMMARY: In patients with pathologically altered erythrocytes, red blood cell exchange is a very efficient therapeutic measure without important side effects. With increasing migration more patients with e.g. severe malaria or sickle cell anemia have to be treated. In minor or bidirectional ABO-mismatched stem cell transplantations after reduced intensity conditioning, hemolysis can be prevented by prophylactic erythrocytapheresis. Other rare indications for red blood cell exchange are advanced erythropoietic protoporphyria and babesiosis. Sickle cell anemia can be treated with hydroxyurea. Transfusions are administered when necessary, but this results in iron overload in the long term. An expensive but safe and very efficient treatment alternative is red blood cell exchange. In cases with stroke, acute chest syndrome and other severe complications, erythrocytapheresis reproducibly breaks the vicious circle of sickling and increasing oxygen deficiency. At the same time one can aim at an exact end hematocrit. In severe malaria, erythrocytapheresis both reduces parasite load to the designated extent and reconstitutes reduced oxygen transport capacity without serious adverse effects. Here we describe our experience of erythrocytapheresis in long-term prophylaxis of complications in sickle cell anemia and sickle cell thalassemia patients. The documentation of improved iron balance was carried out by liver susceptometry.

U2 - 10.1159/000112044

DO - 10.1159/000112044

M3 - SCORING: Journal article

C2 - 21547107

VL - 35

SP - 24

EP - 30

JO - TRANSFUS MED HEMOTH

JF - TRANSFUS MED HEMOTH

SN - 1660-3796

IS - 1

ER -